Kidney Diseases

Papers
(The TQCC of Kidney Diseases is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Renal Injury by SARS-CoV-2 Infection: A Systematic Review45
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis37
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis28
Toll-Like Receptors Regulate the Development and Progression of Renal Diseases26
Drug-Induced Hospital-Acquired Acute Kidney Injury in China: A Multicenter Cross-Sectional Survey25
Incorporation of Urinary Neutrophil Gelatinase-Associated Lipocalin and Computed Tomography Quantification to Predict Acute Kidney Injury and In-Hospital Death in COVID-19 Patients23
A Phase 3 Study of Enarodustat (JTZ-951) in Japanese Hemodialysis Patients for Treatment of Anemia in Chronic Kidney Disease: SYMPHONY HD Study22
The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease21
Tackling Dialysis Burden around the World: A Global Challenge17
suPAR: An Inflammatory Mediator for Kidneys16
Evaluation of Renal Fibrosis by Mapping Histology and Magnetic Resonance Imaging16
Nicotinamide Supplementation Attenuates Renal Interstitial Fibrosis via Boosting the Activity of Sirtuins16
Bone Quality in CKD Patients: Current Concepts and Future Directions – Part I16
Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis15
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis15
Macrophage-Based Combination Therapies as a New Strategy for Cancer Immunotherapy15
Lysosome Depletion-Triggered Autophagy Impairment in Progressive Kidney Injury14
Metabolic Regulation of Fibroblast Activation and Proliferation during Organ Fibrosis13
Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy13
The Role of CXCL12 in Kidney Diseases: A Friend or Foe?12
Acute Kidney Injury Induced by Immune Checkpoint Inhibitors12
Pediatric Acute Kidney Injury to the Subsequent CKD Transition10
Smad3-Targeted Therapy Protects against Cisplatin-Induced AKI by Attenuating Programmed Cell Death and Inflammation via a NOX4-Dependent Mechanism10
Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment10
Venous Thromboembolism in Kidney Diseases and Genetic Predisposition9
Hydrogen: A Novel Treatment Strategy in Kidney Disease9
Trends of Urolithiasis in China: A National Study Based on Hospitalized Patients from 2013 to 20189
Updates on Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in the Treatment of Renal Anemia8
Risk Factors and Outcomes of Acute Kidney Injury in Critically Ill Patients with Coronavirus Disease 20198
Hyperuricemia and Impaired Renal Function: A Prospective Cohort Study7
Physical Function and Clinical Outcomes in Hemodialysis Patients: China Dialysis Outcomes and Practice Patterns Study7
miR-125b Disrupts Mitochondrial Dynamics via Targeting Mitofusin 1 in Cisplatin-Induced Acute Kidney Injury7
Effect of Peer Mentoring on Quality of Life among CKD Patients: Randomized Controlled Trial7
Penicilliumin B Protects against Cisplatin-Induced Renal Tubular Cell Apoptosis through Activation of AMPK-Induced Autophagy and Mitochondrial Biogenesis6
Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia6
Renoprotective Role of Hypoxia-Inducible Factors and the Mechanism6
Similarities and Differences between COVID-19-Associated Nephropathy and HIV-Associated Nephropathy6
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease6
Endostatin in Renal and Cardiovascular Diseases6
Dual-Specificity Phosphatases and Kidney Diseases6
Mechanisms of Scarring in Focal Segmental Glomerulosclerosis6
Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury5
Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications5
SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation5
Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease5
The Neutrophil to Lymphocyte Ratio: An Ideal Marker for Early Diagnosis and Short-Term Prognosis of Acute Kidney Injury?5
Long Noncoding RNA MEG3-205/Let-7a/MyD88 Axis Promotes Renal Inflammation and Fibrosis in Diabetic Nephropathy5
Fibroblast Growth Factor 21 Predicts and Promotes Vascular Calcification in Haemodialysis Patients5
0.035961151123047